Name | SR9011 |
Synonyms | SR9011 Stenabolic Sr9011 3-[[[(4-Chlorophenyl)methyl][(5-nitro-2-thienyl)methyl]amino]methyl]-N-pentyl-1-pyrrolidinecarboxamide |
CAS | 1379686-29-9 |
Molecular Formula | C23H31ClN4O3S |
Molar Mass | 479.0352 |
Density | 1.254±0.06 g/cm3(Predicted) |
Boling Point | 642.8±50.0 °C(Predicted) |
Solubility | DMSO: ≥ 43 mg/mL |
Storage Condition | -20℃ |
Physical and Chemical Properties | Bioactive SR9011 is a Rev-erbα/β agonist with IC50s of 790 nM and 560 nM for Rev-erbα and rev-erbβ, respectively. |
Use | Myocardial infarction is one of the most lethal cardiovascular diseases. Myocardial infarction is due to coronary artery stenosis or spasm, resulting in myocardial acute or persistent ischemia and hypoxia, myocardial cell death. Many pro-inflammatory cells, such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α), are involved in myocardial remodeling due to chemical book3. SR9011 is a Rev-erb alpha/beta agonist, a member of the nuclear receptor family, which has been found to regulate the metabolism of biological tissues. The study found that SR9011 plays an important role in the regulation of autophagy gene rhythm in zebrafish. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.088 ml | 10.438 ml | 20.875 ml |
5 mM | 0.418 ml | 2.088 ml | 4.175 ml |
10 mM | 0.209 ml | 1.044 ml | 2.088 ml |
5 mM | 0.042 ml | 0.209 ml | 0.418 ml |